J Int Assoc Physicians AIDS Care. 1998 Jan;4(1):39-40. Unique Identifier
Many people with HIV in the United States find it a challenge to obtain
life-sustaining and lifesaving drug therapies because of the gaping
holes within the AIDS Drug Assistance Program (ADAP). Thirty-five States
are facing funding problems that will restrict access to ADAP enrollment
and drug availability, and many States very often have differing
regulations and attitudes toward treatment. Besides additional Federal
funding to the ADAP, there is a need for a national standard formulary.
Such a national formulary would address antiretroviral and other drug
accessibility for treating opportunistic diseases. States should also be
required to provide a minimum contribution to match Federal ADAP funds.
The HIV Treatment Improvement Act, introduced in 1997, is a potential
legislative solution. The Act requires federally funded HIV treatment to
conform to new HIV treatment guidelines, improve and expand Medicaid to
include HIV treatments, and improve and expand the ADAP program. Details
of the HIV Treatment Improvement Act are highlighted.
*Acquired Immunodeficiency Syndrome/DRUG THERAPY *Anti-HIV
Agents/ECONOMICS *Financing, Government *HIV Infections/DRUG THERAPY
*Medical Assistance/ORGANIZATION & ADMIN